Skip to main content
Caplight Logo









Anthrogen

Anthrogen

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.anthrogen.com/

Last Round

Seed

Nov 12, 2024

Total Funding Raised

$4.5M

Company Overview

Anthrogen is a bioengineering company that operates a platform to generate molecular machines for applications in human health, carbon capture, and industrial manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, ML Platforms, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Foundation

Keywords

protein language modeldrug discoveryprotein engineeringfoundation modelgenerative biologyfrontier ai labbiotech aidiscrete diffusionprotein designcomputational biologyin silico drug discoveryai for scienceapi platformtherapeutic developmentusage-based billing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anthrogen Comparables

Compare Anthrogen with similar companies based on industry and business-model similarity.

Anthrogen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EvolutionaryScale
92%
310.ai
89%
OpenProtein.AI
85%

Anthrogen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 12, 2024
Pre SeedJun 7, 2024

Anthrogen Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 23, 2025

    Launched Odyssey, a 102B parameter model using Consensus and discrete diffusion.

  • Nov 12, 2024

    $4M raised in Seed round.

Anthrogen Filings

Explore SEC and related filing metadata, where available.

Anthrogen filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Anthrogen's valuation, stock price, and market status.

Is Anthrogen a public or private company?

Anthrogen is a private company.

What is the current stock price of Anthrogen?

Anthrogen is a private company with no public stock price. No recent secondary market data is available.

How much is Anthrogen worth (valuation)?

Valuation information for Anthrogen is not publicly available.

Can I buy Anthrogen stock?

Anthrogen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Anthrogen's last funding round?

Anthrogen's most recent funding round was Seed on November 12, 2024.

Who are the main investors in Anthrogen?

Key investors in Anthrogen include Regenerative Ventures Holdings, BoxGroup, ReGen Ventures.

Will Anthrogen IPO soon?

No public IPO plans have been announced for Anthrogen.

How can I track Anthrogen secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Anthrogen's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range9
Year Founded2024
Last FundingNov 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?